Yong Liu - SINOPHARM Insider

SINOPHARM -- Hong Kong Stock  

HKD 30.65  0.1  0.33%

Chief Legal Advisor and VP

Mr. Liu Yong serves as President of the Company. He has over 25 years of working experience, over 22 years of which is management experience in the pharmaceutical and healthcare products industry. Mr. Liu obtained a bachelors degree in science, majoring in business administration of pharmaceutical enterprises, from China Pharmaceutical University in July 1992, a masters degree in business administration from Fudan University in January 2000 and a doctoral degree in social and administrative pharmacy from China Pharmaceutical University in June 2016. Mr. Liu is a chief pharmacist and a practicing pharmacist. Mr. Liu was employed at Shanghai Pharmaceutical Station from July 1992 to July 1999, and served as the deputy general manager at the marketing department of China National Pharmaceutical Group Shanghai Corporationrationration and the deputy general manager of Shanghai Guoda Drug Chain Store Co., Ltd. from July 1999 to April 2003. Mr. Liu was the general manager and secretary of Party Committee of Sinopharm Holding Shenyang Co., Ltd. from January 2003 to November 2009. He served as vice president of the Company from January 2009 to November 2017, secretary to the Board of the Company from October 2016 to November 2017, and was serving as chief legal advisor of the Company since January 2014. Mr. Liu is also the current executive director of Sinopharm Holding Distribution Co., Ltd. and Beijing Sinopharm Tianyuan Real EstateProperty Management Co., Ltd., and chairman of Sinopharm Holding Beijing Tianxingpuxin BioMed Co., Ltd., Sinopharm Biopharmaceutical Co., Ltd., Sinopharm Holding Guizhou Co., Ltd., Sinopharm Holding Yunnan Co., Ltd., Sinopharm Holding Hainan Co., Ltd., Sinopharm Holding Beijing Huahong Co., Ltd., Sinopharm Online Co., Ltd., Sinopharm Lerentang Pharmaceutical Co., Ltd., Sinopharm Holding Shandong Co., Ltd., Sinopharm Pharmaceutical Logistics Co., Ltd., China National Medicines Co., Ltd. and China National Accord Medicines Co., Ltd.
Age: 47  VP Since 2017      
86 21 2305 2666  http://www.sinopharmholding.com/En

Management Efficiency

The company has return on total asset (ROA) of 4.16 % which means that it generated profit of $4.16 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 15.8 % meaning that it generated $15.8 on every $100 dollars invested by stockholders.
The company has accumulated 6.57 B in total debt with debt to equity ratio (D/E) of 90.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. SINOPHARM has Current Ratio of 1.23 suggesting that it is in a questionable position to pay out its financial obligations in time and when they become due.

Entity Summary

Sinopharm Group Co.Ltd., together with its subsidiaries, distributes pharmaceutical and healthcare solutions in the People?s Republic of China. SINOPHARM (1099) is traded on Hong Kong Stock Exchange in Hong Kong. It is located in Sinopharm Group Co., Ltd.Shanghai, and employs 55,869 people.

Did you try this?

Run Alpha Finder Now

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Hide  View All  NextLaunch Alpha Finder
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add SINOPHARM to your portfolio

Top Management

SINOPHARM Leadership Team
Jindong Deng, Director
Hailiang Liu, Director
Tze Yu, Director
Fang Yao, Executive
Guangpu Li, President
Yong Liu, VP
Qunbin Wang, Director
Yuhua Li, Director
Bin Zhou, Director
Junyu Guo, President
Lulin She, Chairman
Ping Ma, Director
Wanyong Lian, Executive
Qiyu Chen, Director
Ling Li, Director
Deyong Wen, Director
Zhiming Li, President
Zheng Liu, Director
Fumin Zhuo, Director
Xiuchang Jiang, CFO
Wee Tan, Director
Jun Lu, President
Yulin Wei, President
Chang Lyu, Director
Yijian Wu, Director
Wanjun Ma, President
Guangfu Li, President
Dongjiu Li, Director
Shuangjun Xu, President
Wei Liu, Executive, Ph.D
Zhongxi Cai, President, Ph.D
Qi Chen, Chairman

Stock Performance

SINOPHARM Performance Indicators